The 2026 WHO dementia guideline says management of hypertension, or high blood pressure, may be offered to adults with hypertension to reduce cognitive decline and dementia risk. For adults over 65, uneven medicine access and everyday adherence problems limit who gains that protection. The World Health Organization released the second edition of its risk-reduction guideline on 15 July 2026, stating up to 45% of dementia risk involves modifiable factors including high blood pressure, according to the WHO announcement. The promise is practical: treat blood pressure and possibly protect thinking, but only if people can get and stay on treatment.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Register through CDC’s official page — Use this page to review requirements and register directly.
- Read the official guidance from Who — Use this primary source to verify the official guidance.
Table of Contents
- What the guideline recommends
- Why treatment access remains unequal
- Why older adults miss doses
- What helps patients stay treated?
What the guideline recommends
The guideline states hypertension management may be offered specifically to lower cognitive decline or dementia risk in adults with hypertension. The wording is permissive, not mandatory. Clinicians consider it alongside heart, kidney, and stroke care.
That dementia-specific recommendation rests on very-low certainty evidence with a conditional recommendation, as summarized by Guideline Central from the World Health Organization in the guideline summary. Benefit after 65 is therefore uncertain and individualized. Age, other conditions, blood-pressure level, and side effects shape the choice.
Why treatment access remains unequal
Global need is large and control is low. The World Health Organization reports 1.4 billion adults ages 30 to 79 had hypertension in 2024, 33% of that group, with only about 320 million controlled, according to the WHO hypertension fact sheet. Most people with high blood pressure remain untreated or undertreated.
Pharmacy supply explains part of the gap. Only 28% of low-income countries report all WHO-recommended hypertension medicines are generally available in pharmacies or primary-care facilities, the World Health Organization reported. Older adults with limited transport, income, or clinic access feel shortages first.
Why older adults miss doses
High blood pressure is common after 65 and often uncontrolled. CDC Vital Signs reports about 70% of U.S. adults 65 or older have high blood pressure and only about half have it controlled below 140/90 mmHg. No symptoms warn when pressure rises.
Nonadherence is widespread. About 5 million Medicare Part D enrollees 65 or older do not take blood-pressure medicine as directed, with at least 25% skipping doses or stopping, CDC reports. That pattern raises risks of heart disease, stroke, kidney disease, and death. CDC lists direct barriers for older patients as unfilled prescriptions, absent symptoms, complex multi-pill regimens, side effects, forgetting and refill delays, and cost. A Nepalese study of 197 adults 60 and older found similar daily obstacles: fatigue and forgetfulness, poor access to information, time constraints, low family support, low motivation, and stress.
What helps patients stay treated?
Small system changes reduce daily friction. CDC recommends health systems simplify regimens, coordinate care, track home pressures, and lower cost barriers to help older patients stay treated. Patients and caregivers can ask the care team about: Bring the pill bottles, log, and side-effect notes to each visit so dose timing can be adjusted without adding complexity.
- 90-day refills and aligned refill dates
- combination pills or generics where appropriate
- a home monitor plus a simple pressure and dose log
- lower copays, deductibles, or lower-cost options
